Alcon has officially completed the deactivation of two algorithms used for CustomCornea treatment of myopia with or without astigmatism, the U.S. Food and Drug Administration announced. The algorithms ...
June 6, 2007 — A class 1 recall has been announced for the CustomCornea algorithms for myopia with astigmatism (M3) and myopia without astigmatism (A7), the US Food and Drug Administration (FDA) told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback